GHRP-2 y GHRP-6 s elevan estos ejes
"Delayed gastric emptying, which accompanies these drugs, could be a carcinogenic factor with some patients, perhaps those with inflammatory bowel disease." The number of patients actually receiving GLP-1 medications was modest relative to the overall group, Cuomo noted, and the researchers did not have "perfectly complete information" on the exact "dose, duration or adherence" for every individual
Symptoms include dizziness, weakness, confusion, and irritability
[DOI] [PubMed] [Google Scholar] 41.Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W
[oai_citation:0PMC]( Key pointMost findings below come from in vitro or non-human in vivo experiments
These studies assess parameters like bone density, nerve regeneration markers, and inflammatory cell infiltration